These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 4649287)

  • 21. Topics in clinical medicine: treatment of pancreatic insufficiency.
    Iber FL
    Johns Hopkins Med J; 1968 Mar; 122(3):172-9. PubMed ID: 4868819
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy with pancreatic enzyme preparations].
    Holtmann G; Layer P
    Med Monatsschr Pharm; 1993 Feb; 16(2):38-42. PubMed ID: 8441359
    [No Abstract]   [Full Text] [Related]  

  • 23. Pancreatic exocrine insufficiency. IV. The enzyme content of commercial pancreatic supplements.
    Pairent FW; Howard JM
    Arch Surg; 1975 Jun; 110(6):739-41. PubMed ID: 1147772
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combizym-Combizym compositum. Substitution of digestive enzymes].
    Z Allgemeinmed; 1973 Jan; 49(2):84-6. PubMed ID: 4722353
    [No Abstract]   [Full Text] [Related]  

  • 25. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Substitution therapy in liver and pancreatic diseases. Indication and efficiency].
    Kinzlmeier H
    Z Allgemeinmed; 1972 Apr; 48(12):579-82. PubMed ID: 5034165
    [No Abstract]   [Full Text] [Related]  

  • 27. [Substitution of digestive enzymes in elderly patients].
    Jansen W
    Med Welt; 1982 Sep; 33(37):1281-2. PubMed ID: 6182442
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
    Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
    Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
    Pap A; Varró V
    Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutrizym as a pancreatic enzyme replacement.
    Moshal MG
    S Afr Med J; 1974 Jul; 48(35):1489-90. PubMed ID: 4604836
    [No Abstract]   [Full Text] [Related]  

  • 31. Pancreatic extracts.
    Br Med J; 1970 Apr; 2(5702):161-3. PubMed ID: 5440600
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of enzyme substitution on steatorrhea caused by maldigestion].
    Ewers HR
    MMW Munch Med Wochenschr; 1978 Dec; 120(51-52):1715-6. PubMed ID: 105250
    [No Abstract]   [Full Text] [Related]  

  • 33. [Does enzyme substitution therapy reduce pain in chronic pancreatitis?].
    Hansen ML; Rumessen JJ
    Ugeskr Laeger; 2005 Apr; 167(17):1841-4. PubMed ID: 15929329
    [No Abstract]   [Full Text] [Related]  

  • 34. [Enzymatic efficacy of pancreatic substitution preparations. Analysis of tablets].
    Malis F; Fric P
    Vnitr Lek; 1974 Jul; 20(7):658-65. PubMed ID: 4846255
    [No Abstract]   [Full Text] [Related]  

  • 35. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.
    DiMagno EP; Malagelada JR; Go VL; Moertel CG
    N Engl J Med; 1977 Jun; 296(23):1318-22. PubMed ID: 16213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New preparations of pancreatic supplements.
    Drug Ther Bull; 1972 Jan; 10(1):3-4. PubMed ID: 5014554
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of esterase activities in vivo with the new substrate fluorescein-dilauric acid ester].
    Kaffarnik H; Meyer-Bertenrath JG
    Arzneimittelforschung; 1970 Jun; 20(6):754-6. PubMed ID: 5468888
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of the amylase activity in medicinal pancreatin and cholenzim preparations in coated tablets].
    Shaternikov VA; Tsyganov EP; Plokhoĭ VI
    Farmatsiia; 1975; 24(3):42-5. PubMed ID: 1218577
    [No Abstract]   [Full Text] [Related]  

  • 39. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
    Dutta SK; Hubbard VS; Appler M
    Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Demonstration of the activity of an enzyme substitution on secretion disturbances in gastro-intestinal system].
    Capasso F; Sorrentino L
    Arzneimittelforschung; 1972 Jan; 22(1):80-2. PubMed ID: 5067004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.